These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33459531)

  • 41. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers.
    Machado PM; Schäfer M; Strangfeld A; Gossec L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Carmona L; Hyrich KL; Robinson PC; Yazdany J
    Ann Rheum Dis; 2023 May; 82(5):e114. PubMed ID: 33602795
    [No Abstract]   [Full Text] [Related]  

  • 42. Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
    Conway R; Nikiphorou E; Demetriou CA; Low C; Leamy K; Ryan JG; Kavanagh R; Fraser AD; Carey JJ; O'Connell P; Flood RM; Mullan RH; Kane DJ; Ambrose N; Stafford F; Robinson PC; Liew JW; Grainger R; McCarthy GM;
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI151-SI156. PubMed ID: 35258593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.
    Rosenbaum JT; Weisman MH; Shafer C; Aslanyan E; Howard RA; Ogle K; Hamilton H; Reveille JD; Winthrop KL; Choi D
    Ann Rheum Dis; 2023 Jun; 82(6):e138. PubMed ID: 33985940
    [No Abstract]   [Full Text] [Related]  

  • 44. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn
    Schäfer M; Strangfeld A; Hyrich KL; Carmona L; Gianfrancesco M; Lawson-Tovey S; Mateus EF; Gossec L; Robinson PC; Yazdany J; Machado PM
    Ann Rheum Dis; 2023 May; 82(5):e116. PubMed ID: 33648957
    [No Abstract]   [Full Text] [Related]  

  • 46. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum
    Hyrich KL; Schäfer M; Strangfeld A; Carmona L; Gossec L; Mateus EF; Lawson-Tovey S; Gianfrancesco M; Robinson PC; Yazdany J; Machado PM
    Ann Rheum Dis; 2023 Jun; 82(6):e139. PubMed ID: 33985941
    [No Abstract]   [Full Text] [Related]  

  • 47. Challenges and opportunities of the International League of Associations for Rheumatology (ILAR).
    Pineda C
    Reumatol Clin; 2015; 11(5):267-8. PubMed ID: 26278369
    [No Abstract]   [Full Text] [Related]  

  • 48. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 49. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 51. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.
    Ziadé N; El Kibbi L; Hmamouchi I; Abdulateef N; Halabi H; Hamdi W; Abutiban F; El Rakawi M; Eissa M; Masri B
    Int J Rheum Dis; 2020 Nov; 23(11):1550-1557. PubMed ID: 32892516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.
    Robinson PC; Yazdany J; Machado PM
    Curr Opin Rheumatol; 2021 Mar; 33(2):111-116. PubMed ID: 33394601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
    Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
    Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An insight into rheumatology in Thailand.
    Louthrenoo W
    Nat Rev Rheumatol; 2015 Jan; 11(1):55-61. PubMed ID: 25201382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The regional network ADAPTHERA : Rheumatology care through coordinated cooperation: comprehensive, trans-sectoral, covering all health insurance. Initial results].
    Schwarting A; Pfeiff B; Amberger C; Pick D; Hesse M; Jendro M; Engels J; Böttger A; Kuhn C; Majdandzic J; Ziese W; Stadelmann ML; Kessler FW; Dinges H; Ultes-Kaiser S; Droste U; Schmalhofer M; Hazenbiller A; Rector M; Weinmann-Menke J; Triantafyllias K; Becker M; Ataian M; Lablans M; Ueckert F; Panholzer T; Blettner M
    Z Rheumatol; 2016 Dec; 75(10):999-1005. PubMed ID: 27535273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Digital diagnostic support in rheumatology].
    Knitza J; Krusche M; Leipe J
    Z Rheumatol; 2021 Dec; 80(10):909-913. PubMed ID: 34605980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rheumatology update 2020: the focus was on Covid-19].
    Hügle T
    Rev Med Suisse; 2021 Jan; 17(723):214-218. PubMed ID: 33507664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Training the trainees: COVID-19 and rheumatologists of the future.
    Jethwa H; Abraham S
    Clin Med (Lond); 2021 Jan; 21(1):e94-e95. PubMed ID: 33479085
    [No Abstract]   [Full Text] [Related]  

  • 60. [Closer cooperation between primary care physicians and rheumatologists increases the effectiveness of therapeutic care].
    Kutĕj P
    Cesk Zdrav; 1987 Sep; 35(8-9):365-70. PubMed ID: 3499237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.